Mater Cancer Care Centre, Mater Misericordiae Limited

South Brisbane, Queensland QLD 4101

2 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumor, Urothelial Carcinoma

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now